Saquinavir. Clinical pharmacology and efficacy (Q41734947)

8 October 2017

1 reference

title

Saquinavir. Clinical pharmacology and efficacy (English)

1 reference

8 October 2017

1 reference

Vella S

1

1 reference

PubMed ID

9533981

8 October 2017

Floridia M

series ordinal

2

1 reference

8 October 2017

1 March 1998

1 reference

Clinical Pharmacokinetics

8 October 2017

1 reference

8 October 2017

34

1 reference

8 October 2017

189-201

1 reference

8 October 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199834030-00002

8 October 2017

0 references

cites work

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

1 reference

12 December 2020

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

12 December 2020

HIV protease inhibitors: effects on viral maturation and physiologic function in macrophages.

1 reference

12 December 2020

In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages

1 reference

12 December 2020

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

12 December 2020

Rational approaches to resistance: using saquinavir

1 reference

12 December 2020

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

1 reference

12 December 2020

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

1 reference

12 December 2020

Rational design of peptide-based HIV proteinase inhibitors

1 reference

12 December 2020

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

12 December 2020

Advances in the prevention and treatment of Mycobacterium avium disease.

1 reference

12 December 2020

Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors

1 reference

12 December 2020

Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism

1 reference

12 December 2020

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

1 reference

12 December 2020

Safety and activity of saquinavir in HIV infection

1 reference

12 December 2020

Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.

1 reference

12 December 2020

HTLV-III gag protein is processed in yeast cells by the virus pol-protease

1 reference

12 December 2020

Clinical implications of resistance to antiretroviral drugs

1 reference

12 December 2020

Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase

1 reference

12 December 2020

Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro

1 reference

12 December 2020

Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection

1 reference

12 December 2020

Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.

1 reference

12 December 2020

Adding saquinavir to stavudine in patients with advanced HIV-1 infection

1 reference

12 December 2020

Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.

1 reference

12 December 2020

Risks and synergies from drug interactions

1 reference

12 December 2020

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

12 December 2020

A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection

1 reference

12 December 2020

The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study

1 reference

12 December 2020

10.2165/00003088-199834030-00002

Identifiers

DOI

1 reference

PubMed ID

9533981

Dimensions Publication ID

8 October 2017

0 references

1 reference

PubMed ID

9533981